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The title molecule, C16H19NO2, consists of an indane moiety,
which is connected through an N atom to an acetamide group
and a cyclopentane ring. The N atom adopts planar triangular
geometry. Intermolecular interactions, such as – stacking or
hydrogen bonding, were not observed.
Related literature
For background information on the indane pharmacophore,
see: Vaccva et al. (1994); Buckle et al. (1973); Heinzelmann et
al. (1940). For details of the pharmacological activity of the
title compound, see: Sheridan et al. (1990, 1999a,b, 2008);
Frankish et al. (2004). For ionization characteristics, see:






a = 8.1539 (16) A ˚
b = 8.9944 (18) A ˚
c = 10.084 (2) A ˚
 = 87.97 (3)
 = 81.29 (3)
 = 63.15 (3)
V = 651.8 (2) A ˚ 3
Z =2
Mo K radiation
 = 0.09 mm
1
T = 150 K
0.60  0.50  0.30 mm
Data collection
Rigaku Saturn 724 diffractometer
Absorption correction: multi-scan
(CrystalClear; Rigaku, 2006)
Tmin = 0.726, Tmax = 1.000
7260 measured reﬂections
2191 independent reﬂections












max = 0.21 e A ˚ 3
min = 0.23 e A ˚ 3
Data collection: CrystalClear (Rigaku, 2006); cell reﬁnement:
CrystalClear; data reduction: CrystalClear; program(s) used to solve
structure: SHELXS97 (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXL97 (Sheldrick, 2008); molecular graphics:
DIAMOND (Brandenburg, 1998); software used to prepare material
for publication: SHELXL97.
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N-Cyclopentyl-N-(3-oxo-2,3-dihydro-1H-inden-1-yl)acetamide
Tao Zhang, Tom McCabe, Bartosz Marzec, Neil Frankish and Helen Sheridan
Comment 
The indane pharmacophore occurs in many different bioactive molecules. Indinavir, a HIV-1 inhibitor is a protease 
inhibitor in clinical use that contains an indane fragment (Vaccva et al., 1994). Nivemedone, a nitro-indanone has anti-
allergenic activity (Buckle et al., 1973) while many simple indanols demonstrate bronchodilatory activity (Heinzelmann 
et al., 1940). We have demonstrated that indanone derivatives possess smooth muscle relaxant activity and inhibit 
mediator release (Sheridan et al., 1990, 1999a, 1999b; Frankish et al., 2004). In a recent study on bioactivity we 
evaluated the smooth muscle relaxant activity and mediator release inhibition activities demonstrated by a series of 
aminoindanones (Simplício et al., 2004; Sheridan et al., 2008).
The asymmetric unit of the compound presented in this paper contains a single molecule of N-cyclopentyl-N-(3-
oxo-2,3-dihydro-1H -inden-1-yl)acetamide. The geometry around the nitrogen atom can be best described as trigonal 
planar. As there are no flexible hydrogen atoms attached to the nitrogen atom N1 or the oxygen atoms (O1 and O2) 
hydrogen bonding do not prevail in the title compound. The shortest distance between the aromatic rings is 4.150 (9) Å 
and cannot be considered as the π-π stacking interaction.
The packing diagram of the structure, presented in Fig. 2, shows that the molecules are separated and when viewed 
along the crystallographic a-axis seem to form a sheet-like structure in the ab-plane. These sheets pack in the direction of 
the crystallographic c-axis. The shortest separation distance between them is 4.243 (75) Å and a weak Van der Vaals force 
or an electrostatic interaction may be responsible for holding the sheets together.
Experimental 
The title compound was synthesized as reported (Sheridan et al., 2008). N-Bromosuccinimide (672 mg, 3.78 mmol) and a 
catalytic amount of dibenzoylperoxide were added to a solution of indan-1-one (500 mg, 3.78 mmol) in CCl4 (15 ml) and 
the reaction was refluxed for 45 min. After cooling, the reaction was washed with water, dried over Na2SO4, filtered and 
evaporated in vacuo. The resultant was purified by column chromatography over silica gel (eluant, pet. ether:EtOAc, 4:1) 
to yield 3-bromoindan-1-one as an oil. To this 3-bromoindan-1-one solution (200 mg, 0.95 mmol) in dry DCM was added 
cyclopentanamine (80 mg, 0.94 mmol) and triethylamine (200 mg, 1.98 mmol). The reaction was stirred at 0°C for 3 h. 
The solvent was removed in vacuo and the residue was purified directly by flash column chromatography on silica gel 
(eluant, pet. ether:EtOAc, 4:1). After evaporation of the eluent the secondary amine was isolated as an oil (175 mg, 86%). 
To this secondary amine solution (700 mg, 3.25 mmol) in DCM (5 ml) was added triethylamine (657 mg, 0.90 ml, 6.51 
mmol), acetic anhydride (664 mg, 0.61 ml, 6.51 mmol) and DMAP (476 mg, 3.90 mmol). The reaction was stirred at 
room temperature for 2 h. The reaction mixture was then washed with water, dried over Na2SO4, filtered and evaporated 
in vacuo. The residue was purified by column chromatography over silica gel (pet. ether:EtOAc, 4:1) to yield the title 
compound as a white solid (450 mg, 54%). Crystals suitable for X-ray diffraction were obtained after 5 days of slow 
evaporation of an ethanol solution.supplementary materials
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Refinement 
All H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms with C—H = 
0.93 Å for aromatic H atoms, 0.96 Å for CH3 type H atoms, 0.97 Å for CH2 type H atoms and 0.98 Å for CH type H 
atoms, respectively. Uiso(H) values were set at 1.5Ueq(C) for methyl H atoms, and 1.2Ueq(C)for the rest of the H atoms.
Computing details 
Data collection: CrystalClear (Rigaku, 2006); cell refinement: CrystalClear (Rigaku, 2006); data reduction: CrystalClear 
(Rigaku, 2006); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL97 (Sheldrick, 2008); molecular graphics: DIAMOND (Brandenburg, 1998); software used to prepare material 
for publication: SHELXL97 (Sheldrick, 2008).
Figure 1
The molecular structure of the title compound with the atom numbering scheme. Displacement ellipsoids are drawn at the 
50% probability level. H atoms are presented as small spheres of arbitrary radius. supplementary materials
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Figure 2






Hall symbol: -P 1
a = 8.1539 (16) Å
b = 8.9944 (18) Å
c = 10.084 (2) Å
α = 87.97 (3)°
β = 81.29 (3)°
γ = 63.15 (3)°
V = 651.8 (2) Å3
Z = 2
F(000) = 276
Dx = 1.311 Mg m−3
Mo Kα radiation, λ = 0.71073 Å
Cell parameters from 2546 reflections
θ = 2.0–31.2°
µ = 0.09 mm−1
T = 150 K
Prism, colourless
0.60 × 0.50 × 0.30 mm
Data collection 
Rigaku Saturn 724 
diffractometer
Radiation source: fine-focus sealed tube
Graphite monochromator
Detector resolution: 28.5714 pixels mm-1
ω and phi scans
Absorption correction: multi-scan 
(CrystalClear; Rigaku, 2006)
Tmin = 0.726, Tmax = 1.000
7260 measured reflections
2191 independent reflections
2157 reflections with I > 2σ(I)
Rint = 0.026supplementary materials
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Primary atom site location: structure-invariant 
direct methods
Secondary atom site location: difference Fourier 
map




2) + (0.0406P)2 + 0.3106P] 




Δρmax = 0.21 e Å−3
Δρmin = −0.23 e Å−3
Special details 
Experimental. The su's on the Cell Angles were measured.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full 
covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and 
torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. 
An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, 
conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used 
only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 
are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
xyzU iso*/Ueq
O2 0.31603 (15) 0.52993 (14) 0.35282 (11) 0.0247 (3)
N1 0.26193 (16) 0.31399 (15) 0.30730 (12) 0.0180 (3)
C12 0.3026 (2) 0.13741 (18) 0.31299 (14) 0.0178 (3)
H12 0.4075 0.0812 0.3627 0.021*
C5 0.15437 (19) 0.51234 (18) 0.12014 (14) 0.0178 (3)
C9 0.10493 (19) 0.42530 (18) 0.24012 (14) 0.0182 (3)
H9 0.0535 0.3566 0.2071 0.022*
C6 0.0277 (2) 0.67950 (19) 0.12237 (14) 0.0188 (3)
C10 0.3582 (2) 0.38022 (19) 0.36131 (14) 0.0191 (3)
C4 0.2976 (2) 0.4435 (2) 0.01256 (15) 0.0221 (3)
H4 0.3821 0.3311 0.0095 0.027*
C7 −0.1091 (2) 0.72363 (19) 0.24640 (15) 0.0199 (3)
C11 0.5168 (2) 0.2668 (2) 0.43334 (16) 0.0245 (4)
H11A 0.5711 0.3301 0.4669 0.037*
H11B 0.6092 0.1799 0.3720 0.037*
H11C 0.4709 0.2182 0.5069 0.037*
C1 0.0406 (2) 0.7826 (2) 0.01944 (15) 0.0226 (3)
H1 −0.0454 0.8945 0.0219 0.027*
C16 0.1404 (2) 0.10622 (19) 0.38594 (15) 0.0222 (3)
H16A 0.1517 0.0863 0.4801 0.027*
H16B 0.0218 0.2016 0.3793 0.027*
C13 0.3576 (2) 0.04558 (19) 0.17613 (14) 0.0205 (3)
H13A 0.2763 0.1118 0.1132 0.025*supplementary materials
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H13B 0.4852 0.0175 0.1386 0.025*
C3 0.3120 (2) 0.5459 (2) −0.09033 (15) 0.0245 (4)
H3 0.4079 0.5014 −0.1624 0.029*
C14 0.3337 (2) −0.11046 (19) 0.21048 (15) 0.0227 (3)
H14A 0.4397 −0.1927 0.2482 0.027*
H14B 0.3200 −0.1595 0.1313 0.027*
C2 0.1849 (2) 0.7143 (2) −0.08713 (15) 0.0251 (4)
H2 0.1969 0.7811 −0.1566 0.030*
C8 −0.0572 (2) 0.56929 (19) 0.32894 (15) 0.0223 (3)
H8A −0.1624 0.5451 0.3517 0.027*
H8B −0.0181 0.5849 0.4113 0.027*
C15 0.1556 (2) −0.04907 (19) 0.31440 (16) 0.0242 (4)
H15A 0.1640 −0.1346 0.3782 0.029*
H15B 0.0478 −0.0206 0.2704 0.029*
O1 −0.24001 (15) 0.85977 (14) 0.27869 (11) 0.0280 (3)
Atomic displacement parameters (Å2) 
U11 U22 U33 U12 U13 U23
O2 0.0310 (6) 0.0181 (7) 0.0266 (6) −0.0122 (5) −0.0055 (5) 0.0010 (4)
N1 0.0186 (6) 0.0145 (7) 0.0187 (6) −0.0058 (5) −0.0023 (5) 0.0003 (5)
C12 0.0196 (7) 0.0130 (8) 0.0187 (7) −0.0058 (6) −0.0016 (6) 0.0001 (6)
C5 0.0174 (7) 0.0187 (8) 0.0181 (7) −0.0083 (6) −0.0052 (5) 0.0009 (6)
C9 0.0168 (7) 0.0159 (8) 0.0192 (7) −0.0055 (6) −0.0011 (5) −0.0003 (6)
C6 0.0187 (7) 0.0180 (8) 0.0213 (7) −0.0083 (6) −0.0072 (6) 0.0007 (6)
C10 0.0206 (7) 0.0199 (9) 0.0154 (7) −0.0089 (6) 0.0008 (5) −0.0016 (6)
C4 0.0209 (7) 0.0201 (9) 0.0225 (8) −0.0071 (6) −0.0021 (6) −0.0006 (6)
C7 0.0164 (7) 0.0190 (9) 0.0235 (8) −0.0063 (6) −0.0054 (6) −0.0029 (6)
C11 0.0248 (8) 0.0229 (9) 0.0271 (8) −0.0108 (7) −0.0072 (6) −0.0002 (6)
C1 0.0235 (8) 0.0192 (8) 0.0266 (8) −0.0096 (6) −0.0092 (6) 0.0030 (6)
C16 0.0236 (8) 0.0196 (9) 0.0212 (7) −0.0092 (7) 0.0017 (6) −0.0008 (6)
C13 0.0188 (7) 0.0199 (9) 0.0192 (7) −0.0061 (6) −0.0007 (6) −0.0021 (6)
C3 0.0239 (8) 0.0313 (10) 0.0192 (8) −0.0136 (7) −0.0019 (6) 0.0000 (6)
C14 0.0220 (8) 0.0186 (9) 0.0255 (8) −0.0071 (7) −0.0032 (6) −0.0044 (6)
C2 0.0306 (8) 0.0299 (10) 0.0211 (8) −0.0181 (8) −0.0091 (6) 0.0079 (6)
C8 0.0189 (7) 0.0206 (9) 0.0218 (8) −0.0051 (6) 0.0008 (6) −0.0015 (6)
C15 0.0235 (8) 0.0183 (9) 0.0304 (8) −0.0098 (7) −0.0010 (6) −0.0012 (6)
O1 0.0219 (6) 0.0211 (7) 0.0327 (6) −0.0026 (5) −0.0025 (5) −0.0031 (5)
Geometric parameters (Å, º) 
O2—C10 1.2334 (19) C11—H11B 0.9600
N1—C10 1.3571 (19) C11—H11C 0.9600
N1—C9 1.4687 (19) C1—C2 1.389 (2)
N1—C12 1.470 (2) C1—H1 0.9300
C12—C13 1.532 (2) C16—C15 1.541 (2)
C12—C16 1.548 (2) C16—H16A 0.9700
C12—H12 0.9800 C16—H16B 0.9700
C5—C6 1.386 (2) C13—C14 1.523 (2)
C5—C4 1.391 (2) C13—H13A 0.9700supplementary materials
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C5—C9 1.520 (2) C13—H13B 0.9700
C9—C8 1.551 (2) C3—C2 1.394 (2)
C9—H9 0.9800 C3—H3 0.9300
C6—C1 1.391 (2) C14—C15 1.539 (2)
C6—C7 1.476 (2) C14—H14A 0.9700
C10—C11 1.511 (2) C14—H14B 0.9700
C4—C3 1.390 (2) C2—H2 0.9300
C4—H4 0.9300 C8—H8A 0.9700
C7—O1 1.2196 (19) C8—H8B 0.9700
C7—C8 1.514 (2) C15—H15A 0.9700
C11—H11A 0.9600 C15—H15B 0.9700
C10—N1—C9 118.39 (12) C6—C1—H1 120.8
C10—N1—C12 124.30 (12) C15—C16—C12 105.69 (12)
C9—N1—C12 117.30 (12) C15—C16—H16A 110.6
N1—C12—C13 114.87 (12) C12—C16—H16A 110.6
N1—C12—C16 114.41 (12) C15—C16—H16B 110.6
C13—C12—C16 105.21 (12) C12—C16—H16B 110.6
N1—C12—H12 107.3 H16A—C16—H16B 108.7
C13—C12—H12 107.3 C14—C13—C12 102.50 (12)
C16—C12—H12 107.3 C14—C13—H13A 111.3
C6—C5—C4 120.02 (14) C12—C13—H13A 111.3
C6—C5—C9 111.41 (13) C14—C13—H13B 111.3
C4—C5—C9 128.47 (14) C12—C13—H13B 111.3
N1—C9—C5 115.14 (12) H13A—C13—H13B 109.2
N1—C9—C8 115.99 (12) C4—C3—C2 120.98 (15)
C5—C9—C8 103.95 (12) C4—C3—H3 119.5
N1—C9—H9 107.1 C2—C3—H3 119.5
C5—C9—H9 107.1 C13—C14—C15 104.59 (12)
C8—C9—H9 107.1 C13—C14—H14A 110.8
C5—C6—C1 121.56 (14) C15—C14—H14A 110.8
C5—C6—C7 110.07 (13) C13—C14—H14B 110.8
C1—C6—C7 128.36 (14) C15—C14—H14B 110.8
O2—C10—N1 120.77 (14) H14A—C14—H14B 108.9
O2—C10—C11 120.75 (13) C1—C2—C3 120.27 (15)
N1—C10—C11 118.48 (13) C1—C2—H2 119.9
C3—C4—C5 118.77 (15) C3—C2—H2 119.9
C3—C4—H4 120.6 C7—C8—C9 106.08 (12)
C5—C4—H4 120.6 C7—C8—H8A 110.5
O1—C7—C6 126.77 (15) C9—C8—H8A 110.5
O1—C7—C8 125.44 (14) C7—C8—H8B 110.5
C6—C7—C8 107.79 (13) C9—C8—H8B 110.5
C10—C11—H11A 109.5 H8A—C8—H8B 108.7
C10—C11—H11B 109.5 C14—C15—C16 105.85 (12)
H11A—C11—H11B 109.5 C14—C15—H15A 110.6
C10—C11—H11C 109.5 C16—C15—H15A 110.6
H11A—C11—H11C 109.5 C14—C15—H15B 110.6
H11B—C11—H11C 109.5 C16—C15—H15B 110.6
C2—C1—C6 118.40 (15) H15A—C15—H15B 108.7supplementary materials
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C2—C1—H1 120.8
C10—N1—C12—C13 −118.48 (15) C9—C5—C4—C3 176.96 (14)
C9—N1—C12—C13 62.40 (16) C5—C6—C7—O1 −179.07 (14)
C10—N1—C12—C16 119.67 (15) C1—C6—C7—O1 2.3 (2)
C9—N1—C12—C16 −59.45 (16) C5—C6—C7—C8 1.59 (16)
C10—N1—C9—C5 60.63 (17) C1—C6—C7—C8 −177.04 (14)
C12—N1—C9—C5 −120.20 (14) C5—C6—C1—C2 −0.1 (2)
C10—N1—C9—C8 −61.05 (17) C7—C6—C1—C2 178.36 (14)
C12—N1—C9—C8 118.12 (14) N1—C12—C16—C15 147.25 (12)
C6—C5—C9—N1 −135.65 (13) C13—C12—C16—C15 20.25 (16)
C4—C5—C9—N1 48.1 (2) N1—C12—C13—C14 −163.79 (12)
C6—C5—C9—C8 −7.66 (16) C16—C12—C13—C14 −37.07 (15)
C4—C5—C9—C8 176.08 (14) C5—C4—C3—C2 −0.6 (2)
C4—C5—C6—C1 −0.7 (2) C12—C13—C14—C15 39.78 (15)
C9—C5—C6—C1 −177.28 (13) C6—C1—C2—C3 0.6 (2)
C4—C5—C6—C7 −179.41 (12) C4—C3—C2—C1 −0.2 (2)
C9—C5—C6—C7 3.98 (16) O1—C7—C8—C9 174.40 (14)
C9—N1—C10—O2 −0.8 (2) C6—C7—C8—C9 −6.25 (16)
C12—N1—C10—O2 −179.91 (12) N1—C9—C8—C7 135.64 (13)
C9—N1—C10—C11 178.57 (12) C5—C9—C8—C7 8.18 (15)
C12—N1—C10—C11 −0.5 (2) C13—C14—C15—C16 −27.47 (16)
C6—C5—C4—C3 1.0 (2) C12—C16—C15—C14 4.32 (16)